Montanaro Asset Management Ltd boosted its holdings in Stevanato Group S.p.A. (NYSE:STVN – Free Report) by 42.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 200,000 shares of the company’s stock after buying an additional 59,541 shares during the period. Stevanato Group makes up about 1.5% of Montanaro Asset Management Ltd’s investment portfolio, making the stock its 24th largest position. Montanaro Asset Management Ltd owned about 0.07% of Stevanato Group worth $4,196,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Integrated Wealth Concepts LLC acquired a new position in Stevanato Group during the 2nd quarter valued at $59,000. State of Wyoming acquired a new position in shares of Stevanato Group during the third quarter valued at about $75,000. Fifth Third Bancorp raised its position in shares of Stevanato Group by 22.6% during the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after buying an additional 773 shares during the last quarter. Diversify Wealth Management LLC raised its position in shares of Stevanato Group by 23.9% during the first quarter. Diversify Wealth Management LLC now owns 18,353 shares of the company’s stock valued at $252,000 after buying an additional 3,543 shares during the last quarter. Finally, First Bank & Trust lifted its stake in shares of Stevanato Group by 3.4% in the second quarter. First Bank & Trust now owns 18,417 shares of the company’s stock valued at $333,000 after buying an additional 603 shares during the period.
Stevanato Group Trading Down 0.2%
Shares of Stevanato Group stock opened at €15.77 on Monday. The firm has a market capitalization of $4.78 billion, a PE ratio of 27.19, a price-to-earnings-growth ratio of 1.63 and a beta of 0.80. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.73 and a quick ratio of 1.19. The company’s fifty day moving average price is €19.14 and its two-hundred day moving average price is €17.91. Stevanato Group S.p.A. has a 52-week low of €12.05 and a 52-week high of €24.01.
Stevanato Group (NYSE:STVN – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported €0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.17 by (€0.01). The business had revenue of €326.06 million during the quarter. Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. On average, analysts expect that Stevanato Group S.p.A. will post 0.67 EPS for the current year.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the company. William Blair downgraded Stevanato Group from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. UBS Group cut their price target on Stevanato Group from $23.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. Deutsche Bank assumed coverage on Stevanato Group in a research report on Wednesday, October 7th. They issued a “hold” rating for the company. Finally, Citigroup decreased their price objective on Stevanato Group from $26.00 to $20.00 and set a “buy” rating on the stock in a report on Wednesday, November 4th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.
View Our Latest Report on Stevanato Group
Insider Activity
In other Stevanato Group news, Director E Jr bought 25,000 shares of the stock in a transaction that occurred on Friday, November 6th. The shares were acquired at an average price of €13.07 per share, with a total value of €326,750.00. Following the completion of the purchase, the director directly owned 62,424 shares in the company, valued at €815,881.68. The trade was a 66.80% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Mauro Stocchi sold 13,649 shares of the company’s stock in a transaction dated Monday, September 28th. The shares were sold at an average price of €21.50, for a total transaction of €293,453.50. Following the completion of the sale, the insider directly owned 400,000 shares in the company, valued at approximately €8,600,000. The trade was a 3.30% decrease in their position. The SEC filing for this sale provides additional information.
Stevanato Group Profile
Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.
Featured Stories
- Five stocks we like better than Stevanato Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
